Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SRx Health Solutions (SRXH) Net Margin (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Net Margin for 12 consecutive years, with 74.18% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Net Margin fell 7970.0% year-over-year to 74.18%, compared with a TTM value of 52.53% through Sep 2025, down 3235.0%, and an annual FY2024 reading of 32.73%, up 9173.0% over the prior year.
  • Net Margin was 74.18% for Q2 2025 at SRx Health Solutions, down from 13.47% in the prior quarter.
  • Across five years, Net Margin topped out at 225.46% in Q2 2021 and bottomed at 262.92% in Q4 2022.
  • Average Net Margin over 5 years is 44.18%, with a median of 27.29% recorded in 2022.
  • The sharpest move saw Net Margin soared 41094bps in 2021, then crashed -25190bps in 2022.
  • Year by year, Net Margin stood at 46.26% in 2021, then plummeted by -468bps to 262.92% in 2022, then increased by 2bps to 257.82% in 2023, then skyrocketed by 92bps to 20.75% in 2024, then plummeted by -257bps to 74.18% in 2025.
  • Business Quant data shows Net Margin for SRXH at 74.18% in Q2 2025, 13.47% in Q1 2025, and 20.75% in Q4 2024.